Induced Abortion Provision Among a National Sample of Obstetrician–Gynecologists
- 1 March 2019
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 133 (3), 477-483
- https://doi.org/10.1097/aog.0000000000003110
Abstract
To estimate the proportion of obstetrician–gynecologists (ob-gyns) who provided induced abortion in the prior year, disaggregated by surgical and medication methods, and document barriers to provision of medication abortion. In 2016–2017, we conducted a cross-sectional survey of a national sample of American College of Obstetricians and Gynecologists Fellows and Junior Fellows who were part of the Collaborative Ambulatory Research Network. We sent the survey by email, and mailed nonresponders paper surveys. We performed descriptive statistics, χ2 tests, and logistic regression analyses. Sixty-seven percent (655/980) of Collaborative Ambulatory Research Network members responded. Ninety-nine percent reported seeing patients of reproductive age, and 72% reported having a patient in the prior year who needed or wanted an abortion. Among those seeing patients of reproductive age, 23.8% (95% CI 20.5%–27.4%) reported performing an induced abortion in the prior year; 10.4% provided surgical and medication abortion, 9.4% surgical only, and 4.0% medication only. In multivariable analysis, physicians practicing in the Midwest (adjusted odds ratio [AOR] 0.31, 95% CI 0.16–0.60) or South (AOR 0.22, 95% CI 0.11–0.42) had lower odds of provision compared with those practicing in the Northeast, whereas those practicing in an urban inner city (AOR 2.71, 95% CI 1.31–5.60) or urban non–inner-city area (AOR 2.89, 95% CI 1.48–5.64 vs midsize towns, rural areas, or military settings) had higher odds of provision. The most common reasons for not providing medication abortion were personal beliefs (34%) and practice restrictions (19%). Among those not providing medication abortion, 28% said they would if they could write a prescription for mifepristone. Compared with the previous national survey in 2008–2009, abortion provision may be increasing among practicing ob-gyns, although important geographic disparities persist. Few provide medication abortion, but uptake might increase if mifepristone could be prescribed.Keywords
This publication has 10 references indexed in Scilit:
- Estimating abortion provision and abortion referrals among United States obstetrician-gynecologists in private practiceContraception, 2017
- Sixteen Years of Overregulation: Time to Unburden MifeprexThe New England Journal of Medicine, 2017
- Abortion Incidence and Service Availability In the United States, 2014Perspectives on Sexual and Reproductive Health, 2017
- Complications from first-trimester aspiration abortion: a systematic review of the literatureContraception, 2015
- Abortion Provision Among Practicing Obstetrician–GynecologistsObstetrics & Gynecology, 2011
- Has mifepristone medical abortion expanded abortion access in New Mexico? A survey of OB-GYN and Family Medicine physiciansContraception, 2011
- Obstetrician-Gynecologists and Women's Mental Health: Findings of the Collaborative Ambulatory Research Network 2005–2009Obstetrical & Gynecological Survey, 2011
- Obstacles to the Integration of Abortion Into Obstetrics and Gynecology PracticePerspectives on Sexual and Reproductive Health, 2010
- Effect of Mifepristone on Abortion Access in the United StatesObstetrics & Gynecology, 2009
- Predictors of abortion provision among practicing obstetrician-gynecologists: A national surveyAmerican Journal of Obstetrics and Gynecology, 2008